Cargando…
Venture capital activities under uncertainty: US and UK investors behavior
We investigate how in the context of Corporate Venture Capital (CVC), the investment decisions affect the likelihood of their subsequent exit strategies. We use OLS and probit regression as well as Weibull distribution of residual values, given its reliability and validity for studying lifetime anal...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510207/ https://www.ncbi.nlm.nih.gov/pubmed/36191163 http://dx.doi.org/10.1007/s10479-022-04962-3 |
_version_ | 1784797399038820352 |
---|---|
author | Shuwaikh, Fatima Brinette, Souad Khemiri, Sabrina Castro, Rita Grego De |
author_facet | Shuwaikh, Fatima Brinette, Souad Khemiri, Sabrina Castro, Rita Grego De |
author_sort | Shuwaikh, Fatima |
collection | PubMed |
description | We investigate how in the context of Corporate Venture Capital (CVC), the investment decisions affect the likelihood of their subsequent exit strategies. We use OLS and probit regression as well as Weibull distribution of residual values, given its reliability and validity for studying lifetime analysis. Based on a sample of 8722 VC-backed ventures with the first investment dates between 1999 and 2018 in United States (US) and United Kingdom (UK), the results show that the presence of CVCs positively affects the funding amounts and the duration of the investment. CVC funds are more generous and more patient than Independent Venture Capital (IVC) funds regarding their investments in ventures. Moreover, the findings provide evidence that the exit strategies are directly influenced by the funding amounts and the duration of the investment which are influenced, in turn, by the fund type. Greater funding increases the likelihood of IPO exit which is reduced by longer investment duration. Our results are robust to alternative estimation methods, namely two-stage treatment-effects regressions. These results help the various stakeholders (VC funds, investors, ventures) make crucial decisions regarding investment amounts and duration, and exit. |
format | Online Article Text |
id | pubmed-9510207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-95102072022-09-26 Venture capital activities under uncertainty: US and UK investors behavior Shuwaikh, Fatima Brinette, Souad Khemiri, Sabrina Castro, Rita Grego De Ann Oper Res Original Research We investigate how in the context of Corporate Venture Capital (CVC), the investment decisions affect the likelihood of their subsequent exit strategies. We use OLS and probit regression as well as Weibull distribution of residual values, given its reliability and validity for studying lifetime analysis. Based on a sample of 8722 VC-backed ventures with the first investment dates between 1999 and 2018 in United States (US) and United Kingdom (UK), the results show that the presence of CVCs positively affects the funding amounts and the duration of the investment. CVC funds are more generous and more patient than Independent Venture Capital (IVC) funds regarding their investments in ventures. Moreover, the findings provide evidence that the exit strategies are directly influenced by the funding amounts and the duration of the investment which are influenced, in turn, by the fund type. Greater funding increases the likelihood of IPO exit which is reduced by longer investment duration. Our results are robust to alternative estimation methods, namely two-stage treatment-effects regressions. These results help the various stakeholders (VC funds, investors, ventures) make crucial decisions regarding investment amounts and duration, and exit. Springer US 2022-09-23 /pmc/articles/PMC9510207/ /pubmed/36191163 http://dx.doi.org/10.1007/s10479-022-04962-3 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Research Shuwaikh, Fatima Brinette, Souad Khemiri, Sabrina Castro, Rita Grego De Venture capital activities under uncertainty: US and UK investors behavior |
title | Venture capital activities under uncertainty: US and UK investors behavior |
title_full | Venture capital activities under uncertainty: US and UK investors behavior |
title_fullStr | Venture capital activities under uncertainty: US and UK investors behavior |
title_full_unstemmed | Venture capital activities under uncertainty: US and UK investors behavior |
title_short | Venture capital activities under uncertainty: US and UK investors behavior |
title_sort | venture capital activities under uncertainty: us and uk investors behavior |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510207/ https://www.ncbi.nlm.nih.gov/pubmed/36191163 http://dx.doi.org/10.1007/s10479-022-04962-3 |
work_keys_str_mv | AT shuwaikhfatima venturecapitalactivitiesunderuncertaintyusandukinvestorsbehavior AT brinettesouad venturecapitalactivitiesunderuncertaintyusandukinvestorsbehavior AT khemirisabrina venturecapitalactivitiesunderuncertaintyusandukinvestorsbehavior AT castroritagregode venturecapitalactivitiesunderuncertaintyusandukinvestorsbehavior |